Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis.
about
Clinical use and the Italian demand for activated prothrombin complex and activated recombinant factor VII concentratesFirst analysis of 10-year trends in national factor concentrates usage in haemophilia: data from CHARMS, the Canadian Hemophilia Assessment and Resource Management System.Current status of Italian Registries on inherited bleeding disorders.Uncovered needs in the management of inherited bleeding disorders in Italy.Definition of an organisational model for the prevention and reduction of health and social impacts of inherited bleeding disorders.Comparing regional models of congenital bleeding disorders: preliminary steps in the Italian context.von Willebrand's disease: a report from a meeting in the Åland islandsPrinciples of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in ItalyReplacement therapy with recombinant factor IX. A multicentre evaluation of current dosing practices in Italy.The Epidemiology of FVIII Inhibitors in Indian Haemophilia A PatientsMild hemophilia A.Prevalence, incidence, and factor concentrate usage trends of hemophiliacs in TaiwanAlloantibodies in von Willebrand disease.Current challenges of pharmacovigilance in bleeding disorders: converting the burden to benefit.Joint WFH-ISTH session: issues in clinical trial design.The growing number of hemophilia registries: Quantity vs. quality.Registry-based outcome assessment in haemophilia: a scoping study to explore the available evidence.Recommendations for authors of manuscripts reporting inhibitor cases developed in previously treated patients with hemophilia: communication from the SSC of the ISTH.Efficacy and safety of point-of-care ultrasound-guided intra-articular corticosteroid joint injections in patients with haemophilic arthropathy.Establishing a harmonized haemophilia registry for countries with developing health care systems.Type 2M von Willebrand disease - more often misidentified than correctly identified.Current and Emerging Options for the Management of Inherited von Willebrand Disease.Difficulties in the treatment of an Infant with Hemophilia B.Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey.Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy.Web-enabled registry of inherited bleeding disorders in Portugal: conditions and perception of the patients.The natural history of mild haemophilia: a 30-year single centre experience.Immune tolerance induction therapy for patients with hemophilia A and FVIII inhibitors particularly using low-dose regimens.Health-related quality of life and psychological well-being in elderly patients with haemophilia.Type 2N von Willebrand disease: Characterization and diagnostic difficulties.Efficacy of FEIBA for acute bleeding and surgical haemostasis in haemophilia A patients with inhibitors: a multicentre registry in Turkey.Inhibitors in haemophilia B: the Italian experience.
P2860
Q27026389-CE4EA96F-CF8E-442F-8C21-54103CDE8EB1Q30832356-34737BD3-BE2F-416C-9BEC-D63A43115779Q33708942-449A6076-A05C-4A6B-A5A5-ED30EBF66806Q33708980-4664F722-BB51-463C-8BBC-096B3288C29DQ33709003-C0DFCABD-7596-4E7E-AB69-0A02677AD37CQ33837229-14B67C3E-E305-45D4-B12F-525497E95405Q34223268-BB9FF6A9-F68C-417C-BF96-5946EB3E6E64Q34416394-8BA0D768-E7CC-4624-A397-CFA53BDA19CAQ34492760-0F724C3C-75A1-4AAB-B2E5-62B09C16E096Q34569046-C658F843-98BF-4549-89EB-A133E19D21DDQ34614695-B8AB7EA0-3EEA-426C-BF51-AAE8797A73C2Q36463984-1F1CD0B7-2D1A-4F89-84E5-87B7A2FBDFCBQ37065692-35ECDC80-9BA8-4614-B22C-FE943D39B0E5Q37598351-334DC53A-95B6-4ED3-BDCE-B4386FE6DD94Q38206863-1B8B8537-E1C3-4EDD-AE1C-E4C9E6F78829Q38351067-21354F9C-CE25-44F7-96CE-95E1483B1C72Q38783210-5B7DF340-818F-499D-9666-603D27216C53Q38833988-30400627-BB6E-43C8-B6F9-6BA2DC7314ABQ39169130-2E903FAB-A201-4F7E-837B-5A8755B53D7CQ39434363-371FC2C4-74F0-4502-8C94-2B9187113EACQ39876587-E17768F8-8DA7-4791-AAE3-B25E7F843AFFQ41620644-A8507F5F-F5DF-4AE6-B9D9-CBBC8565AF94Q42144707-012931A1-EDBD-4FC7-9A80-6F49F3E5033FQ42236600-85878A94-0159-4419-AB9A-5E6EBE4CA02CQ45865165-29A04133-D20E-4BDC-B13D-1E9F1FA82451Q45870731-1D6081AF-3ABD-4A77-8EAB-CD6EBA6CB63EQ45871908-675EB8AA-6EEF-4DF2-9870-21E05F7DC62FQ45872129-9FC2D8E7-A1AF-4CF9-9B9D-D4A0954D6B61Q45873177-C094CF75-AE12-49BC-9E78-12F87D8CE109Q45874131-CFD7540E-9C96-4F68-8D26-572E17710734Q45875224-C8ACA0F0-93D7-4518-853F-3A85C2142E5AQ45886901-990950CF-5E71-4C4A-94F6-971286A448C5
P2860
Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Italian Registry of Haemophili ...... methodology and data analysis.
@ast
Italian Registry of Haemophili ...... methodology and data analysis.
@en
Italian Registry of Haemophili ...... methodology and data analysis.
@nl
type
label
Italian Registry of Haemophili ...... methodology and data analysis.
@ast
Italian Registry of Haemophili ...... methodology and data analysis.
@en
Italian Registry of Haemophili ...... methodology and data analysis.
@nl
prefLabel
Italian Registry of Haemophili ...... methodology and data analysis.
@ast
Italian Registry of Haemophili ...... methodology and data analysis.
@en
Italian Registry of Haemophili ...... methodology and data analysis.
@nl
P2093
P2860
P921
P1433
P1476
Italian Registry of Haemophili ...... methodology and data analysis.
@en
P2093
Association of Italian Hemophilia Centres Directors
E Oliovecchio
P M Mannucci
P2860
P304
P356
10.1111/J.1365-2516.2008.01679.X
P577
2008-03-18T00:00:00Z